Evidence map›Paper›PMID 25308476›Full record

ArticleOncogene2015

miR-19, a component of the oncogenic miR-17∼92 cluster, targets the DNA-end resection factor CtIP.

D Hühn, A N Kousholt, C S Sørensen, A A Sartori

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The emerging role of miR-19 in glioma.Journal of cellular and molecular medicine · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

D HühnInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
A N KousholtBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark.
C S SørensenBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark.
A A SartoriInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
University of Copenhagen · DKUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNA-19 (miR-19) was recently identified as the key oncogenic component of the polycistronic miR-17∼92 cluster, also known as oncomiR-1, which is frequently upregulated or amplified in multiple tumor types. However, the gene targets and the pathways underlying the tumor-promoting activity of miR-19 still remain largely elusive. CtIP/RBBP8 promotes DNA-end resection, a critical step in the repair of DNA double-strand breaks (DSBs) by homologous recombination (HR), and is considered to function as a tumor suppressor. In this study, we show that miR-19 downregulates CtIP expression by binding to two highly conserved sequences located in the 3'-untranslated region of CtIP mRNA. We further demonstrate that CtIP expression is repressed by miR-19 during continuous genotoxic stress in a p53-dependent manner. Finally, we report that miR-19 impairs CtIP-mediated DNA-end resection, which results in reduced HR levels and DNA damage hypersensitivity. By downregulating CtIP, miR-19 overexpression suppresses the faithful repair of DSBs that is crucial for genome maintenance. Our findings thus provide new mechanistic insight into the oncogenic role of the miR-17∼92 cluster.

Indexed as

RNA Interference3' Untranslated RegionsBase SequenceBinding SitesCarrier ProteinsCell Line, TumorDNA DamageDown-RegulationEndodeoxyribonucleasesGene Expression Regulation, NeoplasticHEK293 CellsHumansMicroRNAsMolecular Sequence DataMultigene FamilyNuclear Proteins3' Untranslated RegionsCarrier ProteinsEndodeoxyribonucleasesMicroRNAsMIRN19A microRNA, humanNuclear ProteinsRBBP8 protein, human

Identifiers

PMID25308476
OpenAlexW2049658618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.